newsfilter
← Latest News
GlobeNewswire·

Trillium Announces Voting Results From the Annual General and Special Meeting of Shareholders

CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (TSX:TRIL) (the "Corporation"), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced the voting results from its A